Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RedBox Rx vs Rixa Health

RedBox Rx
Graded #105

Higher grade

vs+9.700000000000003
Rixa Health
Graded #320

Lower grade

The verdict

RedBox Rx takes it — 70.2/100 to 60.5/100.

RedBox Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RedBox Rx is a US telehealth pharmacy (parent company Hy-Vee) offering compounded GLP-1 weight management with flat, dose-independent pricing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRixa Health +3
42
45
Dose & formulationRedBox Rx +32
83
51
Clinical oversightRedBox Rx +8
93
85
Labs & monitoringRedBox Rx +21
84
63
FulfillmentRixa Health +6
72
78
Contract termsEven
41
41
RedBox Rx · left barRixa Health · right bar

The numbers

MetricRedBox RxRixa Health
WeighScore70.2/10060.5/100
GradeCC
Scorecard rank#105#320
Semaglutide$269/mo (all doses, 6-month plan, compounded)Not disclosed
Tirzepatide$429/moNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
RedBox Rx

Graded #105 · C

Strengths

  • Flat, dose-independent pricing on both semaglutide and tirzepatide
  • Offers both weekly injections and daily oral tablets
  • Includes unlimited provider follow-ups, a metabolic panel and a dietitian session
  • Backed by grocery-pharmacy parent company Hy-Vee

Where it loses points

  • Does not serve every state (for example Mississippi is excluded)
  • Does not publicly name its compounding pharmacy
Rixa Health

Graded #320 · C

Strengths

  • Functional-medicine, root-cause clinical approach
  • Compounded and oral semaglutide plus tirzepatide offered
  • Board-certified DO and FNP providers with years of experience
  • Medication bundled with visits into a single price
  • No charge until after approval

Where it loses points

  • No public monthly pricing; quoted only during consultation
  • Relies on compounded GLP-1, which is not FDA-approved as a finished drug
  • A handful of states still listed as coming soon
  • Branded GLP-1 medications are not the primary offering
  • Requires ongoing monthly follow-up commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard